Menú

ISAC
ISAC (Intervencions Sanitàries i Activitats Comunitàries)

RESPONSABLE DEL GRUP
avatar_investigadors.jpg
Francisco Martín Luján
fmartin.tgn.ics@gencat.cat
avatar_grups_recerca.png

Publicacions

A pharmacist-led educational and audit & feedback strategy to reduce antibiotic prescription in primary care: the AFA study

A. SOLER, A. HUGUET, A. LEIVA, C. VICENS, F. BEJARANO-ROMERO, E. SEMPERE, T. IZQUIERDO, M. PARERA, R. SECO, M. FAGES, A. MEDINA, L. CASTILLO-PALOMARES, E. LÓPEZ-GUERRERO, B. FERRER, L. UGARRIZA, M. LLARENA and L. GALLARDO-ALFARO
Bmc Primary Care. 2025 Jul 19; . doi:10.1186/s12875-025-02933-8; PMID:40684119

Veure més:
The usefulness of studying visceral fat for early stratification of atherogenic risk: from conventional anthropometry to more accurate measurements.

Luján FM and Alberich RS
CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS. 2025 Nov 1; . doi:10.1016/j.arteri.2025.500874; PMID:41276337

Veure més:
Impact and Effectiveness of COVID-19 mRNA Vaccination Against COVID-19 Hospitalisation in Paediatrics: A Cohort Study Using Two Linked Data Sources in Spain.

Castillo-Cano B, Riefolo F, Villalobos F, Martín-Pérez M, Messina D, Elbers R, Brink-Kwakkel D, Bissacco CA, Segundo E, Saiz LC, Leache L, Barbieri E, Vaz T, Gini R, Klungel O and Martín-Merino E
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2025 Nov 1; . doi:10.1002/pds.70239; PMID:41125425

Veure més:
Clinical Course, Outcomes, and Risk Factors of Myocarditis and Pericarditis Following Administration of mRNA-1273 Vaccination: A Protocol for a Federated Real-World Evidence Vaccine Safety Study Using Data from Five European Data Sources.

Zwiers LC, Grobbee DE, Schneijdenberg R, Baljé C, St Laurent S, Esposito DB, Zhu L, Urdaneta VV, Emilebacker M, Weibel D, Villalobos F, Bissacco CA, Urchueguía Fornes A, Carreras-Martínez JJ, Desalegn AA, Lupattelli A, Wang L, Wheler J, Ehrenstein V, Morris D, Fry C, Jansen M, Goodale BM and Ong DSY
Vaccines. 2025 Jul 16; . doi:10.3390/vaccines13070755; PMID:40733732

Veure més:
Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study.

Nasreen S, Jiang Y, Lu H, Lee A, Cutland CL, Gentile A, Giglio N, Macartney K, Deng L, Liu B, Sonneveld N, Bellamy K, Clothier HJ, Sepulveda Kattan G, Naus M, Naveed Z, Janjua NZ, Nguyen L, Hviid A, Poukka E, Perälä J, Leino T, Chandra LA, Thobari JA, Park BJ, Choi NK, Jeong NY, Madhi SA, Villalobos F, Solórzano M, Bissacco CA, Carreras-Martínez JJ, Correcher-Martínez E, Urchueguía-Fornes A, Roy D, Yeomans A, Aurelius T, Morton K, Di Mauro G, Sturkenboom MC, Sejvar JJ, Top KA, Batty K, Ghebreab L, Griffin JB, Petousis-Harris H, Buttery J, Black S and Kwong JC
Vaccine. 2025 Jul 11; . doi:10.1016/j.vaccine.2025.127291; PMID:40440921

Veure més:

Patronat

Col·laboradors

Acreditacions